Quality Improvement Summit 2016

Shared Decision Making and Prostate Cancer Screening

Danil V. Makarov, Margaret Holmes-Rovner, David R. Rovner, Timothy Averch, Michael J. Barry, Kristin Chrouser, William F. Gee, Kate Goodrich, Mike Haynes, Murray Krahn, Christopher Saigal, Harold C. Sox, Dawn Stacey, Christopher Tessier, Robert L. Waterhouse, Angela Fagerlin

Research output: Contribution to journalArticle

Abstract

Introduction: The American Urological Association Quality Improvement Summit occurs regularly to provide education and promote dialogue around the issues of quality improvement and patient safety. Nearly all prostate cancer screening guidelines recommend shared decision making strategies when determining whether prostate specific antigen testing is right for a specific patient. This summit, held in partnership with the Society for Medical Decision Making, focused on techniques to identify and understand patient values in relation to prostate cancer screening and treatment, and to promote incorporation of shared decision making into prostate cancer screening discussions. Methods: Information presented at the Quality Improvement Summit was provided by physicians and leading experts in the field of shared decision making. The open forum of this summit encouraged contributions from participants about their personal experiences with shared decision making and their thoughts on the tools presented during the day. Results: Shared decision making supports collaboration between physician and patient in situations where there are multiple preference sensitive options. Conclusions: Practitioners should include formal shared decision making procedures surrounding prostate specific antigen testing in their practices to ensure that testing is in accordance with patient values and desired outcomes. Tools and strategies like those reviewed in this Quality Improvement Summit are invaluable for alleviating potential burden on providers, ensuring communication and improving quality of care.

Original languageEnglish (US)
Pages (from-to)444-451
Number of pages8
JournalUrology Practice
Volume5
Issue number6
DOIs
StatePublished - Nov 1 2018
Externally publishedYes

Fingerprint

Quality Improvement
Early Detection of Cancer
Prostatic Neoplasms
Decision Making
Prostate-Specific Antigen
Physicians
Quality of Health Care
Patient Safety
Communication
Guidelines
Education

Keywords

  • decision making
  • decision support techniques
  • patient preference
  • prostate-specific antigen
  • social values

ASJC Scopus subject areas

  • Urology

Cite this

Makarov, D. V., Holmes-Rovner, M., Rovner, D. R., Averch, T., Barry, M. J., Chrouser, K., ... Fagerlin, A. (2018). Quality Improvement Summit 2016: Shared Decision Making and Prostate Cancer Screening. Urology Practice, 5(6), 444-451. https://doi.org/10.1016/j.urpr.2017.11.005

Quality Improvement Summit 2016 : Shared Decision Making and Prostate Cancer Screening. / Makarov, Danil V.; Holmes-Rovner, Margaret; Rovner, David R.; Averch, Timothy; Barry, Michael J.; Chrouser, Kristin; Gee, William F.; Goodrich, Kate; Haynes, Mike; Krahn, Murray; Saigal, Christopher; Sox, Harold C.; Stacey, Dawn; Tessier, Christopher; Waterhouse, Robert L.; Fagerlin, Angela.

In: Urology Practice, Vol. 5, No. 6, 01.11.2018, p. 444-451.

Research output: Contribution to journalArticle

Makarov, DV, Holmes-Rovner, M, Rovner, DR, Averch, T, Barry, MJ, Chrouser, K, Gee, WF, Goodrich, K, Haynes, M, Krahn, M, Saigal, C, Sox, HC, Stacey, D, Tessier, C, Waterhouse, RL & Fagerlin, A 2018, 'Quality Improvement Summit 2016: Shared Decision Making and Prostate Cancer Screening', Urology Practice, vol. 5, no. 6, pp. 444-451. https://doi.org/10.1016/j.urpr.2017.11.005
Makarov DV, Holmes-Rovner M, Rovner DR, Averch T, Barry MJ, Chrouser K et al. Quality Improvement Summit 2016: Shared Decision Making and Prostate Cancer Screening. Urology Practice. 2018 Nov 1;5(6):444-451. https://doi.org/10.1016/j.urpr.2017.11.005
Makarov, Danil V. ; Holmes-Rovner, Margaret ; Rovner, David R. ; Averch, Timothy ; Barry, Michael J. ; Chrouser, Kristin ; Gee, William F. ; Goodrich, Kate ; Haynes, Mike ; Krahn, Murray ; Saigal, Christopher ; Sox, Harold C. ; Stacey, Dawn ; Tessier, Christopher ; Waterhouse, Robert L. ; Fagerlin, Angela. / Quality Improvement Summit 2016 : Shared Decision Making and Prostate Cancer Screening. In: Urology Practice. 2018 ; Vol. 5, No. 6. pp. 444-451.
@article{b6d8d6973f90458bb42ac5ff24f8330b,
title = "Quality Improvement Summit 2016: Shared Decision Making and Prostate Cancer Screening",
abstract = "Introduction: The American Urological Association Quality Improvement Summit occurs regularly to provide education and promote dialogue around the issues of quality improvement and patient safety. Nearly all prostate cancer screening guidelines recommend shared decision making strategies when determining whether prostate specific antigen testing is right for a specific patient. This summit, held in partnership with the Society for Medical Decision Making, focused on techniques to identify and understand patient values in relation to prostate cancer screening and treatment, and to promote incorporation of shared decision making into prostate cancer screening discussions. Methods: Information presented at the Quality Improvement Summit was provided by physicians and leading experts in the field of shared decision making. The open forum of this summit encouraged contributions from participants about their personal experiences with shared decision making and their thoughts on the tools presented during the day. Results: Shared decision making supports collaboration between physician and patient in situations where there are multiple preference sensitive options. Conclusions: Practitioners should include formal shared decision making procedures surrounding prostate specific antigen testing in their practices to ensure that testing is in accordance with patient values and desired outcomes. Tools and strategies like those reviewed in this Quality Improvement Summit are invaluable for alleviating potential burden on providers, ensuring communication and improving quality of care.",
keywords = "decision making, decision support techniques, patient preference, prostate-specific antigen, social values",
author = "Makarov, {Danil V.} and Margaret Holmes-Rovner and Rovner, {David R.} and Timothy Averch and Barry, {Michael J.} and Kristin Chrouser and Gee, {William F.} and Kate Goodrich and Mike Haynes and Murray Krahn and Christopher Saigal and Sox, {Harold C.} and Dawn Stacey and Christopher Tessier and Waterhouse, {Robert L.} and Angela Fagerlin",
year = "2018",
month = "11",
day = "1",
doi = "10.1016/j.urpr.2017.11.005",
language = "English (US)",
volume = "5",
pages = "444--451",
journal = "Urology Practice",
issn = "2352-0779",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Quality Improvement Summit 2016

T2 - Shared Decision Making and Prostate Cancer Screening

AU - Makarov, Danil V.

AU - Holmes-Rovner, Margaret

AU - Rovner, David R.

AU - Averch, Timothy

AU - Barry, Michael J.

AU - Chrouser, Kristin

AU - Gee, William F.

AU - Goodrich, Kate

AU - Haynes, Mike

AU - Krahn, Murray

AU - Saigal, Christopher

AU - Sox, Harold C.

AU - Stacey, Dawn

AU - Tessier, Christopher

AU - Waterhouse, Robert L.

AU - Fagerlin, Angela

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Introduction: The American Urological Association Quality Improvement Summit occurs regularly to provide education and promote dialogue around the issues of quality improvement and patient safety. Nearly all prostate cancer screening guidelines recommend shared decision making strategies when determining whether prostate specific antigen testing is right for a specific patient. This summit, held in partnership with the Society for Medical Decision Making, focused on techniques to identify and understand patient values in relation to prostate cancer screening and treatment, and to promote incorporation of shared decision making into prostate cancer screening discussions. Methods: Information presented at the Quality Improvement Summit was provided by physicians and leading experts in the field of shared decision making. The open forum of this summit encouraged contributions from participants about their personal experiences with shared decision making and their thoughts on the tools presented during the day. Results: Shared decision making supports collaboration between physician and patient in situations where there are multiple preference sensitive options. Conclusions: Practitioners should include formal shared decision making procedures surrounding prostate specific antigen testing in their practices to ensure that testing is in accordance with patient values and desired outcomes. Tools and strategies like those reviewed in this Quality Improvement Summit are invaluable for alleviating potential burden on providers, ensuring communication and improving quality of care.

AB - Introduction: The American Urological Association Quality Improvement Summit occurs regularly to provide education and promote dialogue around the issues of quality improvement and patient safety. Nearly all prostate cancer screening guidelines recommend shared decision making strategies when determining whether prostate specific antigen testing is right for a specific patient. This summit, held in partnership with the Society for Medical Decision Making, focused on techniques to identify and understand patient values in relation to prostate cancer screening and treatment, and to promote incorporation of shared decision making into prostate cancer screening discussions. Methods: Information presented at the Quality Improvement Summit was provided by physicians and leading experts in the field of shared decision making. The open forum of this summit encouraged contributions from participants about their personal experiences with shared decision making and their thoughts on the tools presented during the day. Results: Shared decision making supports collaboration between physician and patient in situations where there are multiple preference sensitive options. Conclusions: Practitioners should include formal shared decision making procedures surrounding prostate specific antigen testing in their practices to ensure that testing is in accordance with patient values and desired outcomes. Tools and strategies like those reviewed in this Quality Improvement Summit are invaluable for alleviating potential burden on providers, ensuring communication and improving quality of care.

KW - decision making

KW - decision support techniques

KW - patient preference

KW - prostate-specific antigen

KW - social values

UR - http://www.scopus.com/inward/record.url?scp=85054356064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054356064&partnerID=8YFLogxK

U2 - 10.1016/j.urpr.2017.11.005

DO - 10.1016/j.urpr.2017.11.005

M3 - Article

VL - 5

SP - 444

EP - 451

JO - Urology Practice

JF - Urology Practice

SN - 2352-0779

IS - 6

ER -